Last update:
Coronavirus (COVID-19)
AI-designed universal vaccine clears first human trial, targets future coronavirus threats with needle-free delivery
The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side effects.
Jun 7, 2026
0
126
COVID-19 vaccine boosters may help protect against future animal coronaviruses, research suggests
COVID-19 vaccine boosters not only protect against SARS-CoV-2—the virus behind the most recent pandemic—but may also help protect against some future coronaviruses that risk spreading from animals to humans, Cambridge researchers ...
Jul 1, 2026
0
12
COVID-19 outbreak
Coronavirus disease 2019 (COVID-19) is the infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
A pneumonia of unknown cause detected in Wuhan, China was first reported to the World Health Organization Country Office in China on 31 December 2019 and recognised as a pandemic on 11 March 2020.
Reported illnesses have ranged from mild symptoms to severe illness and death for confirmed COVID-19 cases.
More information: WHO, CDC, global cases.
Follow us on Google News for the latest updates on the coronavirus.
Scientists measure hidden quantum forces that could power a new generation of pharmaceutical drugs
It's one thing to design a pharmaceutical drug. It's another to know if and why it actually works; not on paper or in a computer model, but inside the chaotic world of living systems, where proteins twist into shape, atoms ...
Jun 25, 2026
0
42
Single amino acid change may help viruses jump from bat to human
Most pandemics start when a pathogen spreads from animals to humans. It's a leading explanation for the COVID-19 pandemic: The SARS-CoV-2 virus, which causes COVID-19, is a cousin of coronaviruses that live in bats.
Jun 21, 2026
1
19
Tiny protein tail helps one immune gene fight two very different viruses
Our genomes contain hundreds of genes with antiviral jobs that are called into action when a virus succeeds in infecting one of our cells. By acting cooperatively, these genes provide defense against a wide range of viruses, ...
Jun 8, 2026
0
4
Lab evolution recreates COVID's path to omicron in months, reveals key conditions
A key step in the origin of many pandemics occurs when an animal-borne virus infects humans and then evolves to spread more efficiently from person to person. That is why scientists and physicians keep a close watch on viruses ...
Jun 2, 2026
0
114
T cells may be key to stopping measles virus—and its deadly relatives
T cells are some of the immune system's most important warriors. They can stop tumor growth and even fight off severe infections. Now scientists at La Jolla Institute for Immunology (LJI) have discovered how T cells target ...
Jun 2, 2026
0
4
Antiviral ensitrelvir cuts risk of COVID-19 in household contacts by two-thirds, study finds
The antiviral drug ensitrelvir prevents infection in household contacts of COVID-19 patients when given within 72 hours after symptom onset in the index patient, according to a Phase III randomized controlled trial published ...
May 15, 2026
0
22
Diseases can spread between apartments via shared ventilation, study shows
Airborne diseases like measles, influenza and COVID-19 can easily spread between units in multi-family buildings via a type of bathroom ventilation system commonly used around the world, new research suggests. The study, ...
May 13, 2026
0
16
'Atomic snapshots' of proofreading enzyme could lead to better COVID-19 drugs
The closest-ever detailed look at a key enzyme inside the virus that causes COVID-19 could lead to more effective treatment of the disease. Nucleotide analogs are a common type of antiviral medication that mimic the genetic ...
May 6, 2026
0
5
Brazilian tree compounds block SARS-CoV-2 at multiple stages, lab tests show
A study has revealed that galloylquinic acids extracted from the leaves of Copaifera lucens Dwyer, a tree endemic to Brazil primarily found in the Atlantic Forest, have a multi-targeted effect against SARS-CoV-2, the virus ...
Apr 30, 2026
0
21
An unexpected limit to SARS-CoV-2's immune defenses reveal a hidden virus trade-off
A new study has revealed that while SARS-CoV-2 can weaken part of the body's early immune response, it may also unintentionally trigger another defense that helps cells fight back. A new collaborative study has revealed a ...
Apr 27, 2026
0
10
Why the early U.S. COVID-19 death toll may be 155,000 higher
The COVID-19 pandemic's early death toll was much higher than the official U.S. count, according to a new study that spotlights dramatic disparities in the uncounted deaths.
Mar 18, 2026
0
11
Broad COVID-19 vaccination makes economic sense, especially for older adults, modeling study finds
As the nation gears up for the rollout of an updated COVID-19 vaccine, a new study shows the economic benefits of continued broad vaccination in adults.
Aug 13, 2025
0
110
Cruise ship air pollution at port cities could make viral infections worse
Air pollution from cruise ships could be damaging the health of people living in port cities by increasing inflammation and susceptibility to viruses such as the common cold and COVID-19. New research from the University ...
Jul 10, 2026
0
4
GLP-1 agonists may help people with diabetes and long COVID, study in mice suggests
GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well. Findings from experiments on mice, published in the Journal of Virology, suggest ...
Jul 9, 2026
0
2
COVID-19 vaccine study that was blocked from CDC journal is published elsewhere
A study on COVID-19 vaccine effectiveness has finally been published after being blocked from a government health journal.
Jun 24, 2026
0
10
SARS and MERS trigger immune brake that shuts down antiviral defenses, study finds
Researchers from Trinity have discovered how two deadly coronaviruses (SARS1 and MERS) outsmart one of our most important antiviral defenses by shutting down parts of the immune system. The findings help explain why certain ...
Jun 18, 2026
0
7
FDA approves Xocova for COVID-19 postexposure prophylaxis
The U.S. Food and Drug Administration has approved Shionogi's Xocova (ensitrelvir), an oral antiviral, for postexposure prophylaxis (PEP) of COVID‑19 in adults and adolescents aged 12 years and older.
Jun 9, 2026
0
19
The new Ebola outbreak: Expert explains rare virus strain spreading in Africa
Growing global alarm surrounds the Ebola outbreak in Central Africa, which has now been declared a public health emergency of international concern by the World Health Organization. The current outbreak is centered in the ...
May 19, 2026
0
27
